LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000023 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
15
Total Shares
17,569
Total Value
$2,894,431.20
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 1,607 | $58.49 | $93,993.43 | 34,619 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Exercise/Conversion | 466 | $80.72 | $37,615.52 | 35,085 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 699 | $198.71 | $138,894.93 | 34,386 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 53 | $200.08 | $10,604.12 | 34,333 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 698 | $201.09 | $140,363.54 | 33,635 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 950 | $201.73 | $191,640.27 | 32,685 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 697 | $202.79 | $141,342.75 | 31,988 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 668 | $203.63 | $136,023.97 | 31,320 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 743 | $204.74 | $152,125.46 | 30,577 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 1,457 | $205.79 | $299,841.42 | 29,120 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 1,588 | $206.89 | $328,541.96 | 27,532 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 2,457 | $207.91 | $510,823.08 | 25,075 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 4, 2026 | Sale | 3,413 | $208.80 | $712,620.75 | 21,662 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 1,607 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Employee Stock Option (right to buy) | Derivative | Mar 4, 2026 | Exercise/Conversion | 466 | $0.00 | $0.00 | 0 | Direct | โ | View Details |